medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2014, Number 3

Next >>

Arch Inv Mat Inf 2014; 6 (3)

Ablación con láser en lesiones vulvares asociadas a virus del papiloma humano

Hernández CNJ, Garay SG

Language: Spanish
References: 15
Page: 99-104
PDF size: 86.34 Kb.


ABSTRACT

Introduction: Genital infection with human papillomavirus (HPV) is the most common sexual disease transmission, two thirds of them are diagnosed in women. The incidence of vulvar condylomata has been reported in 3.4%. There is a 30% incidence of spontaneous regression. There pharmacological and surgical treatments. Laser ablation is also appropriate treatment, with cure rates of 87%. Objective: To determine the persistence and recurrence of vulvar lesions in patients with human papilloma virus treated with laser ablation, with tracking service colposcopy. Material and methods: An observational, descriptive, cross-sectional and retrospective study, where patient records were analyzed who were given treatment laser ablation in vulva, by infection of human papilloma virus and monitoring, in the Colposcopy Service in the Hospital of Gynecology and Obstetrics, Maternal and Child Institute of the State of Mexico, January 2011 to December 2012. Persistence and recurrence were evaluated within six months after treatment and after 6 months to 12 months, respectively. Results: During the Term, 14 patients treated with laser ablation in vulva, by infection of human papilloma virus found. The persistence was 28.6% (n = 4), recurrence was 21.4% (n = 3). Conclusion: Laser ablation was effective in the treatment, cure, recurrence, persistence and complication rates.


REFERENCES

  1. Wheeler CM. Natural history of human papillomavirus, cytologic and histologic abnormalities, and cancer, Obstet Gynecol Clin North Am, 2008; 35 (4): 519-536.

  2. Doerfler D, Bernhaus A, Koffmel A, Sam C, Koelle D, Joura EA. Human papilloma virus infection prior to coitarche, Am J Obstet Gynecol, 2009; 200 (5): 487.e1-5.

  3. Nelson EL, Stockdale CK. Vulvar and vaginal VPH di­sease, Obstet Gynecol Clin North Am, 2013; 40 (2): 359-376.

  4. Buck HW Jr. Warts (genital), Clin Evidence, 2010; 08: 1602.

  5. Pimentel CG, Manterola AD. Manejo de la condilomatosis perianal, Rev Mex Coloproctología, 2007; 13 (2): 42-47.

  6. Gunter J. Genital and perinatal warts: new treatment opportunities for human papillomavirus infection, Am J Obstet Gynecol, 2003; 189 (3 Suppl): S3-11.

  7. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J et al. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD vulvar oncology subcommittee, J Reprod Med, 2005; 50 (11): 807-810.

  8. Ghurani GB, Penalver MA. An update on vulvar cancer, Am J Obstet Gynecol, 2001; 185 (2): 294-299.

  9. Foster DC. Vulvar disease, Obstet Gynecol, 2002; 100 (1): 145-163.

  10. Gagné HM. Colposcopy of the vagina and vulva, Obstet Gynecol Clin North Am, 2008; 35 (4): 659-669.

  11. Azizjalali M, Ghaffarpour GH, Mousavifard B. CO2 laser therapy versus cryotherapy in treatment or genital warts; a Randomized Controlled Trial (RCT), Iran J Microbiol, 2012; 4 (4): 187-190.

  12. Díaz ML. Human papilloma virus. Prevention and treatment, Obstet Gynecol Clin N Am, 2008; 35 (2): 199-217.

  13. Aynaud O, Buffet M, Roman P, Plantier F, Dupin N. Study of persistence and recurrence rates in 106 patients with condyloma and intraepithelial neoplasia after CO2 laser treatment, Eur J Dermatol, 2008; 18 (2): 153-158.

  14. von Gruenigen VE, Gibbons HE, Gibbins K, Jenison EL, Hopkins MP. Surgical treatments for vulvar and vaginal dysplasia: a randomized controlled trial, Obstet Gynecol, 2007; 109 (4): 942-947.

  15. Yanofsky VR, Patel RV, Goldenberg G. Genital warts: a comprehensive review, J Clin Aesthet Dermatol, 2012; 5 (6): 25-36.




2020     |     www.medigraphic.com